Sana Biotechnology, Inc.
(NASDAQ : SANA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 5.26%140.920.0%$1089.53m
AMGNAmgen, Inc. 0.84%248.951.3%$709.58m
SNSSSunesis Pharmaceuticals, Inc. -2.18%8.510.7%$594.88m
NVAXNovavax, Inc. 1.97%179.7480.0%$528.85m
ILMNIllumina, Inc. -0.09%403.373.5%$527.61m
GILDGilead Sciences, Inc. 0.14%65.111.0%$506.15m
REGNRegeneron Pharmaceuticals, Inc. -0.25%475.172.7%$424.91m
VRTXVertex Pharmaceuticals, Inc. 1.46%213.351.9%$365.10m
ALXNAlexion Pharmaceuticals, Inc. 0.35%155.012.0%$327.81m
BIIBBiogen, Inc. 0.92%268.171.7%$308.69m
EXASEXACT Sciences Corp. -2.30%125.5418.4%$188.77m
OCGNOcugen, Inc. 0.72%6.960.0%$185.95m
BNTXBioNTech SE 6.68%122.140.0%$183.14m
CRSPCRISPR Therapeutics AG -3.85%115.740.6%$172.12m
NBIXNeurocrine Biosciences, Inc. 0.71%93.354.9%$170.52m

Company Profile

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.